About Solstice Pharmaceuticals
Solstice Pharmaceuticals develops and commercialises innovative ultrasound contrast agents based on novel microfluidic technology. Utilising our new contrast-agent platform we aim to support and enable the healthcare sector by positively impacting the diagnostic and therapeutic capacity of ultrasound. More information on www.solsticepharma.com
Contact
Solstice Pharmaceuticals B.V.
Capitool 41-6
7521 PL Enschede
The Netherlands
Gepubliceerde artikelen
